305 related articles for article (PubMed ID: 23838364)
1. Risk profile in extracranial/intracranial bypass surgery--the role of antiplatelet agents, disease pathology, and surgical technique in 168 direct revascularization procedures.
Schubert GA; Biermann P; Weiss C; Seiz M; Vajkoczy P; Schmiedek P; Thomé C
World Neurosurg; 2014 Nov; 82(5):672-7. PubMed ID: 23838364
[TBL] [Abstract][Full Text] [Related]
2. Outcome in adult patients with hemorrhagic moyamoya disease after combined extracranial-intracranial bypass.
Jiang H; Ni W; Xu B; Lei Y; Tian Y; Xu F; Gu Y; Mao Y
J Neurosurg; 2014 Nov; 121(5):1048-55. PubMed ID: 25127415
[TBL] [Abstract][Full Text] [Related]
3. Outcome of repeat revascularization surgery for moyamoya disease after an unsuccessful indirect revascularization. Clinical article.
Pandey P; Steinberg GK
J Neurosurg; 2011 Aug; 115(2):328-36. PubMed ID: 21529138
[TBL] [Abstract][Full Text] [Related]
4. Effects of Surgery and Antiplatelet Therapy in Ten-Year Follow-Up from the Registry Study of Research Committee on Moyamoya Disease in Japan.
Yamada S; Oki K; Itoh Y; Kuroda S; Houkin K; Tominaga T; Miyamoto S; Hashimoto N; Suzuki N;
J Stroke Cerebrovasc Dis; 2016 Feb; 25(2):340-9. PubMed ID: 26654669
[TBL] [Abstract][Full Text] [Related]
5. The necessity of technical excellence and safety in EC-IC bypass surgery.
Nakaji P
World Neurosurg; 2014 Nov; 82(5):577-8. PubMed ID: 24007695
[No Abstract] [Full Text] [Related]
6. Extracranial-intracranial bypass in atherosclerotic cerebrovascular disease: report of a single centre experience.
Muroi C; Khan N; Bellut D; Fujioka M; Yonekawa Y
Br J Neurosurg; 2011 Jun; 25(3):357-62. PubMed ID: 21501047
[TBL] [Abstract][Full Text] [Related]
7. Unstable moyamoya disease: clinical features and impact on perioperative ischemic complications.
Funaki T; Takahashi JC; Takagi Y; Kikuchi T; Yoshida K; Mitsuhara T; Kataoka H; Okada T; Fushimi Y; Miyamoto S
J Neurosurg; 2015 Feb; 122(2):400-7. PubMed ID: 25423271
[TBL] [Abstract][Full Text] [Related]
8. Indications and results of direct cerebral revascularization in the modern era.
Kalani MY; Rangel-Castilla L; Ramey W; Nakaji P; Albuquerque FC; McDougall CG; Spetzler RF; Zabramski JM
World Neurosurg; 2015 Mar; 83(3):345-50. PubMed ID: 25451808
[TBL] [Abstract][Full Text] [Related]
9. Operative wound-related complications after cranial revascularization surgeries.
Takanari K; Araki Y; Okamoto S; Sato H; Yagi S; Toriyama K; Yokoyama K; Murotani K; Matsui S; Wakabayashi T; Kamei Y
J Neurosurg; 2015 Nov; 123(5):1145-50. PubMed ID: 26140494
[TBL] [Abstract][Full Text] [Related]
10. Extra-intracranial standard bypass in the elderly: perioperative risk, bypass patency and outcome.
Sandow N; von Weitzel-Mudersbach P; Rosenbaum S; König S; Buchert R; Mehl SR; Garbe A; Vajkoczy P
Cerebrovasc Dis; 2013; 36(3):228-35. PubMed ID: 24135535
[TBL] [Abstract][Full Text] [Related]
11. Local Vasogenic Edema without Cerebral Hyperperfusion after Direct Revascularization Surgery for Moyamoya Disease.
Sakata H; Fujimura M; Mugikura S; Sato K; Tominaga T
J Stroke Cerebrovasc Dis; 2015 Jul; 24(7):e179-84. PubMed ID: 25957910
[TBL] [Abstract][Full Text] [Related]
12. Aspirin resistance in patients with hemodynamic cerebral ischemia undergoing extracranial-intracranial bypass surgery.
Jussen D; Horn P; Vajkoczy P
Cerebrovasc Dis; 2013; 35(4):355-62. PubMed ID: 23635905
[TBL] [Abstract][Full Text] [Related]
13. Impact of extracranial-intracranial bypass on cerebrovascular reactivity and clinical outcome in patients with symptomatic moyamoya vasculopathy.
Han JS; Abou-Hamden A; Mandell DM; Poublanc J; Crawley AP; Fisher JA; Mikulis DJ; Tymianski M
Stroke; 2011 Nov; 42(11):3047-54. PubMed ID: 21903951
[TBL] [Abstract][Full Text] [Related]
14. Clinical features and long-term outcomes of moyamoya disease: a single-center experience with 528 cases in China.
Liu XJ; Zhang D; Wang S; Zhao YL; Teo M; Wang R; Cao Y; Ye X; Kang S; Zhao JZ
J Neurosurg; 2015 Feb; 122(2):392-9. PubMed ID: 25423267
[TBL] [Abstract][Full Text] [Related]
15. Effects of extracranial-intracranial bypass for patients with hemorrhagic moyamoya disease: results of the Japan Adult Moyamoya Trial.
Miyamoto S; Yoshimoto T; Hashimoto N; Okada Y; Tsuji I; Tominaga T; Nakagawara J; Takahashi JC;
Stroke; 2014 May; 45(5):1415-21. PubMed ID: 24668203
[TBL] [Abstract][Full Text] [Related]
16. Early versus Delayed Extracranial-Intracranial Bypass Surgery in Symptomatic Atherosclerotic Occlusion.
Rice CJ; Cho SM; Taqui A; Moore NZ; Witek AM; Bain MD; Uchino K
Neurosurgery; 2019 Nov; 85(5):656-663. PubMed ID: 30239897
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcome of standard extracranial-intracranial bypass surgery in patients with symptomatic atherosclerotic occlusion of the internal carotid artery.
Mendelowitsch A; Taussky P; Rem JA; Gratzl O
Acta Neurochir (Wien); 2004 Feb; 146(2):95-101. PubMed ID: 14963741
[TBL] [Abstract][Full Text] [Related]
18. Analysis of ischemic cerebral lesions using 3.0-T diffusion-weighted imaging and magnetic resonance angiography after revascularization surgery for ischemic disease.
Murai Y; Mizunari T; Takagi R; Amano Y; Mizumura S; Komaba Y; Okubo S; Kobayashi S; Teramoto A
Clin Neurol Neurosurg; 2013 Jul; 115(7):1063-70. PubMed ID: 23177181
[TBL] [Abstract][Full Text] [Related]
19. Surgical management of Moyamoya disease and syndrome: Current concepts and personal experience.
Thines L; Petyt G; Aguettaz P; Bodenant M; Himpens FX; Lenci H; Henon H; Gauthier C; Hossein-Foucher C; Cordonnier C; Lejeune JP
Rev Neurol (Paris); 2015 Jan; 171(1):31-44. PubMed ID: 25555850
[TBL] [Abstract][Full Text] [Related]
20. Stroke prevention by direct revascularization for patients with adult-onset moyamoya disease presenting with ischemia.
Kim T; Oh CW; Kwon OK; Hwang G; Kim JE; Kang HS; Cho WS; Bang JS
J Neurosurg; 2016 Jun; 124(6):1788-93. PubMed ID: 26636391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
